Praetorian Acquisition Corp. (PTOR) - 10-K Summary
Business Context and Reporting Period
Company: Praetorian Acquisition Corp. (PTOR)
Reporting Period: Fiscal year ended December 31, 2025 (Inception: September 29, 2025)
Business Type: Special Purpose Acquisition Company (SPAC) incorporated in the Cayman Islands.
Objective: To effect a merger, amalgamation, or similar business combination with one or more target businesses, with a focus on traditional sectors transformable by automation and artificial intelligence.
Status: As of December 31, 2025, the Company had no operating revenues. The Initial Public Offering (IPO) was consummated on January 26, 2026, subsequent to the reporting period.
Key Financial Metrics
Financial Position (as of December 31, 2025):
- Total Assets: $264,716 (Comprising $25,000 in prepaid expenses and $239,716 in deferred offering costs).
- Total Liabilities: $288,920 (Including $124,650 promissory note to related party, $128,386 accrued offering costs, and $35,884 accrued expenses).
- Shareholder's Deficit: $(24,204).
- Net Loss: $(49,204) for the period from inception through December 31, 2025.
- Cash Balance: $0 as of December 31, 2025.
- IPO Proceeds: $220,000,000 from the sale of 22,000,000 Units at $10.00 per Unit (Jan 26, 2026).
- Over-Allotment: $33,000,000 from the sale of 3,300,000 additional Units (Mar 16, 2026).
- Private Placement: $5,000,000 from the sale of 5,000,000 Private Placement Warrants to the Sponsor.
- Trust Account: $253,000,000 deposited (approx. $10.00 per Public Share).
- Deferred Underwriting Fees: $6,600,000 (plus potential additional fees upon over-allotment exercise).
Material Changes and Subsequent Events
The financial statements reflect the pre-IPO period. Significant capitalization events occurred after December 31, 2025:
- Initial Public Offering: Consummated on January 26, 2026. The Company transitioned from a working capital deficit of $(263,920) to a cash position of approximately $2.47 million immediately post-IPO.
- Over-Allotment Exercise: Underwriters exercised the full over-allotment option on March 12, 2026, closing March 16, 2026. This removed the forfeiture risk on 1,100,000 Founder Shares.
- Repayment of Debt: The promissory note to the Sponsor ($129,650) was repaid in full on January 26, 2026.
Outlook, Risks, and Management Commentary
Combination Period: The Company must complete an initial business combination by January 26, 2028 (24 months from IPO), or April 26, 2028 if a letter of intent is executed within the first 24 months. Failure to do so will result in liquidation and redemption of Public Shares.
Management Team: Led by CEO Dr. Justin Di Rezze and CFO Peter Ondishin. The team has prior SPAC experience with Inflection Point Acquisition Corp. (IPAX, IPXX, IPCX).
Key Risks:
- Internal Controls: Management identified a material weakness in internal controls over financial reporting due to inadequate segregation of duties and insufficient written policies.
- Dilution: Public shareholders face significant dilution from Founder Shares (purchased at ~$0.003/share) and Private Placement Warrants. The implied value per share upon combination is estimated at $7.23 compared to the $10.00 public investment.
- Trust Account Claims: While the Sponsor has agreed to indemnify the Trust Account against third-party claims, the Company has not verified the Sponsor's ability to satisfy these obligations.
- Geopolitical Factors: Ongoing conflicts in Ukraine and the Middle East may impact the ability to identify targets or the financial performance of potential targets.
Investor Verification Checklist
- Trust Account Balance: Verify the current balance in the Trust Account ($253,000,000 as of March 16, 2026) and interest earned to date.
- Redemption Rights: Confirm the specific redemption price per share and the deadline for the initial business combination (Jan 26, 2028).
- Founder Share Dilution: Review the anti-dilution provisions for Class B Founder Shares, which may convert at a ratio greater than 1:1, significantly impacting public shareholder ownership.
- Related Party Transactions: Monitor the $25,000/month administrative fee paid to the Sponsor and any potential Working Capital Loans (up to $1.5M convertible to warrants).
- Internal Control Remediation: Assess the Company's plan to remediate the material weakness in internal controls identified in the 10-K.